UHealth - University of Miami Health System

Rakesh Singal, M.D.

Información general

Rakesh  Singal, M.D.

Contacto

Idiomas

  • English
  • Hindi

Certificaciones

  • American Board of Internal Medicine
  • American Board of Internal Med-Medical Oncology

Especialidades

  • Internal Medicine
  • Hematology/Oncology - Internal Medicine
  • Medical Oncology - Internal Medicine

Puestos

  • Associate Professor of Medicine

Intereses clínicas

Prostate, Kidney, Bladder, Testis and Adrenocortical Cancer

Intereses de
investigación

Prostate cancer, epigenetics, transcriptional regulation, DNA methylation, chromatin structure, biomarkers

Premios

South Florida Super Doctors
Advanced Research Career Development Award
Awarded by the Minneapolis Society of Internal Medicine and Minnesota Medical Foundation
Awarded by DNA Methylation Society
University of Minnesota

Educación

Graduate
Maulana Azad Medical College
Residency
MetroHealth Medical Center
Fellowship
University of Minnesota

Publicaciones

  • Singal R, Ramachandran K, Gordian E, Quintero C, Zhao W, Reis IM. Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy. Clin Genitourin Cancer. 2014 Aug 1. pii: S1558-7673(14)00155-4. doi: 10.1016/j.clgc.2014.07.008. [Epub ahead of print]
  • Ramachandran K, Singal R. DNA methylation and field cancerization. Epigenomics. 2012 Jun;4(3):243-5
  • Gordian E, Ramachandran K, Reis IM, Manoharan M, Soloway MS, Singal R. Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate disease. Cancer Epidemiol Biomarkers Prev. 2010;19:1984-1991.

E-mail a Friend